mycobacterium ulcerans

3rd Jun 2019

Qurient Announces Positive Phase 2a Data of Novel Antibiotic for the Treatment of Tuberculosis

  June 03, 2019 09:00 AM Eastern Daylight Time   SEONGNAM-SI, South Korea–(BUSINESS WIRE)–Qurient Co. Ltd. today announced positive results from the Phase 2a EBA (early […]